Cancer News and Research

Latest Cancer News and Research

Roundup: Calif. cigarette tax hike too close to call; Mass. insurance mandate not as contentious; Sept. 11 health fund cancer coverage ruling delayed

Tobacco companies poured nearly $47 million into defeating Proposition 29, a $1-a-pack tax hike on cigarettes, but the measure was narrowly leading in early returns Tuesday despite the hard-fought campaign. The tax increase would raise $810 million a year for cancer research and smoking cessation programs, and it would give California -- which currently has a lower tobacco tax than 32 other states -- the 16th-highest cigarette tax in the nation. … The vote would be a huge win for the public health groups that sponsored the measure, including the American Cancer Society.

6 Jun 2012

Split-course RT valuable after hormone-resistant prostate cancer relapse

A split course of high-dose radiotherapy in men with progressive, hormone-refractory prostate cancer is effective and has an acceptable toxicity profile, report Australian researchers.

6 Jun 2012

Work pattern affects night shift–breast cancer link

The risk for breast cancer increases significantly with both the number of years of night shift work and the cumulative number of shifts, Danish researchers have discovered.

6 Jun 2012

Better diagnosis of breast cancer could come from simple blood test

Scientists have discovered that a simple blood test could lead to better diagnosis and treatment for early-stage breast cancer patients, according to an Article published Online First in The Lancet Oncology.

6 Jun 2012

New tool helps researchers to better understand Type 2 human diabetes

With Type 2 human diabetes climbing at alarming rates in the United States, researchers are seeking treatments for the disease, which has been linked to obesity and poor diet. Now biologists at Southern Methodist University, Dallas, report they have developed a new tool that will help researchers better understand this deadly disease.

6 Jun 2012

AB Science announces data from development program of masitinib in GIST

AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), announces today that data from the development program of masitinib in gastrointestinal stromal tumors (GIST) have been presented as part of three presentations delivered at the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting, 1-5 June in Chicago, Illinois.

6 Jun 2012

Economist infographic depicts probability of dying from NCDs by country

The Economist's "Graphic Detail" blog features an infographic depicting the probability of dying from a non-communicable disease by country. "You are more likely to be killed by a non-communicable disease (NCD), like cancer or heart disease, than anything else," the blog notes.

6 Jun 2012

Four live cases using Toshiba's Infinix-i vascular X-ray systems to be showcased at NCVH

Enabling physicians to transition between cardiac and peripheral work seamlessly during a single procedure, Toshiba America Medical Systems, Inc.'s Infinix-i vascular X-ray systems facilitate better physician workflow and support improved patient care.

6 Jun 2012

STELARA effectively reduces signs and symptoms of active psoriatic arthritis

Patients with active psoriatic arthritis receiving the interleukin (IL)-12/23 inhibitor STELARA (ustekinumab) experienced significant improvements in signs and symptoms of the disease, according to new findings presented today from a Janssen Research & Development, LLC, (Janssen)-sponsored investigational study.

6 Jun 2012

Abbott announces results from HUMIRA Phase 3 study on axSpA

Abbott today announced results from the open-label extension of the Phase 3 ABILITY-1 investigational study of HUMIRA (adalimumab), which assessed the improvement in signs and symptoms of disease for patients with active axial spondyloarthritis (axSpA) who have no X-ray evidence of structural damage.

6 Jun 2012

Patients with type 2 diabetes have 20% increased risk of blood cancers

Patients with type 2 diabetes have a 20 percent increased risk of developing blood cancers, such as non-Hodgkin lymphoma, leukemia and myeloma, according to a new meta-analysis led by researchers at The Miriam Hospital.

6 Jun 2012

Cardio-protective drug during cancer treatment may prevent heart damage in children

About 75 percent of children with leukemia who take chemotherapy face life-threatening heart problems as they age, but an international study led by a University of Rochester Medical Center investigator shows that giving a cardio-protective drug during cancer treatment may prevent the damage.

6 Jun 2012

bioTheranostics’ CancerTYPE ID molecular test improves overall survival for patients with CUP

bioTheranostics, developer of innovative oncology diagnostic tests and solution provider for metastatic cancer, today announced study results showing that tumor profiling with its CancerTYPE ID molecular test helped guide site-specific chemotherapy and improve overall survival for patients with carcinoma of unknown primary site.

6 Jun 2012

UCSF's ACT program helps amputees reach their athletic goals

Carlos Gonzalez stands out from an athletic group gathered on a grassy field at the UCSF Mission Bay campus. The gregarious 32-year-old sports a stylish fauxhawk and walks with a confident yet understated swagger. He's training to become a mixed martial arts (MMA) fighter.

6 Jun 2012

Aeterna Zentaris announces results from perifosine Phase 1 trial on multiple myeloma

Aeterna Zentaris Inc. today announced that Phase 1 trial results for the Company's oral anticancer compound, perifosine, in multiple myeloma, have been published in the online May 2012 issue of the British Journal of Haematology.

6 Jun 2012

Firefly surgical technology sheds new light on kidney cancers

A surgical technology called Firefly is shedding new light on kidney cancers and helping doctors at MedStar Georgetown University Hospital remove tumors more safely and more efficiently while sparing the rest of the healthy kidney.

6 Jun 2012

BioLineRx receives two U.S. patent allowances for BL-1021 to treat neuropathic pain

BioLineRx, a biopharmaceutical development company, announced today that two Notices of Allowance have been issued by the United States Patent and Trademark Office (USPTO) for BL-1021, an orally available small molecule for treating neuropathic pain.

6 Jun 2012

NTNU’s EIR software to be showcased at 7th World Research Congress of the EAPC

What happens when doctors cannot cure a disease? What is the best way to make patients comfortable and have the best quality of life possible in the time they have left? Researchers at the Norwegian University of Science and Technology (NTNU) have developed software that can be used with an iPad or other tablet to help record patient pain levels to help doctors in developing further treatment.

6 Jun 2012

VGXI, OncoSec partner to produce interleukin-12 plasmid DNA

OncoSec Medical Inc., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announced today that the Company has entered into an exclusive cGMP manufacturing agreement with VGXI Inc. (VGXI) for the production of interleukin-12 plasmid DNA.

6 Jun 2012

BioInvent, ThromboGenics to regain global rights to TB-403 from Roche

ThromboGenics NV and co-development partner BioInvent International announce today that they will regain global rights to TB-403 from Roche.

6 Jun 2012

Cancer News and Research

Latest Cancer News and Research

Roundup: Calif. cigarette tax hike too close to call; Mass. insurance mandate not as contentious; Sept. 11 health fund cancer coverage ruling delayed

Split-course RT valuable after hormone-resistant prostate cancer relapse

Work pattern affects night shift–breast cancer link

Better diagnosis of breast cancer could come from simple blood test

New tool helps researchers to better understand Type 2 human diabetes

AB Science announces data from development program of masitinib in GIST

Economist infographic depicts probability of dying from NCDs by country

Four live cases using Toshiba's Infinix-i vascular X-ray systems to be showcased at NCVH

STELARA effectively reduces signs and symptoms of active psoriatic arthritis

Abbott announces results from HUMIRA Phase 3 study on axSpA

Patients with type 2 diabetes have 20% increased risk of blood cancers

Cardio-protective drug during cancer treatment may prevent heart damage in children

bioTheranostics’ CancerTYPE ID molecular test improves overall survival for patients with CUP

UCSF's ACT program helps amputees reach their athletic goals

Aeterna Zentaris announces results from perifosine Phase 1 trial on multiple myeloma

Firefly surgical technology sheds new light on kidney cancers

BioLineRx receives two U.S. patent allowances for BL-1021 to treat neuropathic pain

NTNU’s EIR software to be showcased at 7th World Research Congress of the EAPC

VGXI, OncoSec partner to produce interleukin-12 plasmid DNA

BioInvent, ThromboGenics to regain global rights to TB-403 from Roche

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in